AnaptysBio Inc (ANAB)
25.01
-0.06
(-0.24%)
USD |
NASDAQ |
May 20, 16:00
25.02
+0.01
(+0.04%)
After-Hours: 20:00
AnaptysBio Free Cash Flow: -134.14M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -134.14M |
| December 31, 2023 | -121.61M |
| September 30, 2023 | -97.84M |
| June 30, 2023 | -79.00M |
| March 31, 2023 | -77.62M |
| December 31, 2022 | -73.95M |
| September 30, 2022 | -88.41M |
| June 30, 2022 | -77.79M |
| March 31, 2022 | -44.83M |
| December 31, 2021 | -47.29M |
| September 30, 2021 | 15.30M |
| June 30, 2021 | 5.373M |
| March 31, 2021 | -23.05M |
| December 31, 2020 | -14.73M |
| September 30, 2020 | -67.90M |
| June 30, 2020 | -73.18M |
| March 31, 2020 | -69.24M |
| Date | Value |
|---|---|
| December 31, 2019 | -70.32M |
| September 30, 2019 | -66.91M |
| June 30, 2019 | -59.71M |
| March 31, 2019 | -53.14M |
| December 31, 2018 | -49.57M |
| September 30, 2018 | -42.01M |
| June 30, 2018 | -30.73M |
| March 31, 2018 | -24.26M |
| December 31, 2017 | -19.73M |
| September 30, 2017 | -20.36M |
| June 30, 2017 | -19.54M |
| March 31, 2017 | -15.17M |
| December 31, 2016 | -9.08M |
| September 30, 2016 | -6.203M |
| June 30, 2016 | -5.045M |
| March 31, 2016 | -9.399M |
| December 31, 2015 | -9.932M |
Free Cash Flow Range, Past 5 Years
-134.14M
Minimum
Mar 2024
15.30M
Maximum
Sep 2021
-63.34M
Average
-69.78M
Median
Free Cash Flow Benchmarks
| XOMA Corp | -18.20M |
| Fate Therapeutics Inc | -139.78M |
| Ocular Therapeutix Inc | -87.11M |
| Apellis Pharmaceuticals Inc | -550.90M |
| Sutro Biopharma Inc | -119.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -37.25M |
| Cash from Investing (Quarterly) | 68.62M |
| Cash from Financing (Quarterly) | -13.63M |
| Free Cash Flow Per Share (Quarterly) | -1.391 |
| Free Cash Flow to Equity (Quarterly) | -37.28M |
| Free Cash Flow Yield | -20.13% |